Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 20 mg/10 mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
The hazard: Potency, impurity or stability failure
The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
What the notice says: Subpotent product:out of specification assay results observed during long term stability testing.
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0238-2026
- Published
- December 24, 2025
- Risk level
- Class III
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Somerset Therapeutics LLC
- Product type
- Prescription & OTC drugs
- Units affected
- 71,310 10mL vials
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot#: A250043, EXP Date 06/30/2026
Products covered by this recall
Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.
Check your product
The notice names 12 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- A250043
- 30
- 2026 — 71
- 310 10mL vials
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 06
- 30
- 2026 — 71
- 310 10mL vials
NDC number
On the carton and again on the bottle or blister label.
- 70069-161-01
Package size
Match the net weight or the piece count on the front of the pack.
- 20 mg
- 10 mL
- 2 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Potency
Somerset Therapeutics LLC — The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Do not stop a prescription on your own. For most conditions an uncertain dose is safer than no dose while you get advice.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
- Keep the carton and the leaflet — the lot number is usually printed only on the outer pack.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: SOMERSET THERAPEUTICS LLC — 300 Franklin Square Dr, Somerset, NJ, 08873-4187
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Somerset Therapeutics LLC prescription & otc drugs recalled?
Subpotent product:out of specification assay results observed during long term stability testing. Subpotent product:out of specification assay results observed during long term stability testing.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code A250043, 30, 2026 — 71; best-by date 06 or 30. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 7 months ago
Somerset Therapeutics LLC Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL recall: Failed Impurities/Degradation Specifications - OOS impurities result observed
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were…
-
Class III · 10 months ago
Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 200mg/20mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
-
Class III · 10 months ago
Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 10 mg/5 mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 11 days ago
Carolina Infusion, LLC Quad-Mix Injectable, Packaged in single-use dosage syringes recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tirzepatide/Cyanocobalamin 26/2 MG/ML Injectable recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.